Abera Bioscience (ABERA.SL) Stock Price

Abera Bioscience Price

CLOSED
6.40
​
Market closed

Abera Bioscience stock price

Access this data via the Eulerpool API

Abera Bioscience business model & stock analysis

Abera Bioscience AB engages in the research and development of pharmaceutical products. The company is headquartered in Uppsala, Uppsala and currently employs 5 full-time employees. The company went IPO on 2021-02-24. Abera Bioscience is platform and vaccine development company active in the medical, molecular and microbiological field. The Company’s purpose is to develop vaccine candidates based on its vaccine delivery platform to late pre-clinical or early clinical phase and to find licensing partners for further development of the vaccines. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and immunooncology. The business is located around the Nordic market.

Frequently asked questions about Abera Bioscience

Converted at the current exchange rate, the Abera Bioscience share trades at 0.57 EUR (6.40 SEK).

The revenue cannot currently be calculated for Abera Bioscience.

The profit cannot currently be calculated for Abera Bioscience.

The P/E ratio cannot be calculated for Abera Bioscience at the moment.

The P/S cannot be calculated for Abera Bioscience currently.

The Eulerpool Quality Score for Abera Bioscience is 2/10.

The ISIN of Abera Bioscience is SE0015245097. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Abera Bioscience is ABERA.SL. The ticker symbol is used to trade Abera Bioscience shares on the stock exchange.

Fair ValueTerminal
6.72 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website aberabio.com
Country
Sweden
Currency
SEK
Initial public offering
Feb 24, 2021
ISIN
SE0015245097
Cusip
W00830112
Market capitalization
119.23 M SEKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
6.18
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-54.20 %
Last updated Oct 8, 2026, 7:16 AM

Abera Bioscience Peer Group